Scaffold proteins are critical hubs within cells that have the ability to modulate upstream signaling molecules and their downstream effectors to fine-tune biological responses. Although they can serve as focal points for association of signaling molecules and downstream pathways that regulate tumorigenesis, little is known about how the tumor microenvironment affects the expression and activity of scaffold proteins. This study demonstrates that hypoxia, a common element of solid tumors harboring low oxygen levels, regulates expression of a specific variant of the scaffold protein AKAP12 (Akinase anchor protein 12), AKAP12v2, in metastatic melanoma. In turn, through a kinome-wide phosphoproteomic and MS study, we demonstrate that this scaffolding protein regulates a shift in protein kinase A (PKA)-mediated phosphorylation events under hypoxia, causing alterations in tumor cell invasion and migration in vitro, as well as metastasis in an in vivo orthotopic model of melanoma. Mechanistically, the shift in AKAP12-dependent PKAmediated phosphorylations under hypoxia is due to changes in AKAP12 localization vs. structural differences between its two variants. Importantly, our work defines a mechanism through which a scaffold protein can be regulated by the tumor microenvironment and further explains how a tumor cell can coordinate many critical signaling pathways that are essential for tumor growth through one individual scaffolding protein.AKAP12 | melanoma | metastasis S caffold proteins, also known as anchoring proteins, are of crucial importance within cells because they allow dynamic association of signaling molecules, often present in low abundance, by concentrating them at discrete subcellular localizations, forming intricate signal transduction complexes. However, the mechanisms by which scaffold proteins are regulated within the tumor microenvironment and how altering their expression can result in a switch between kinase targets and promote tumor progression remain unknown. Importantly, scaffold proteins have recently been identified as new therapeutic targets, highlighting the necessity of understanding the biology behind these potential targets (1). In this paper, we focus on the scaffold protein AKAP12, which is a member of the larger "A Kinase Anchoring Protein" family that regulates signal transduction from the cell surface to the cytoskeleton. Previous studies have reported that AKAP12 binds to protein kinase A (PKA), protein kinase C (PKC), Src, and the actin cytoskeleton, all involved in tumorigenesis (2). However, the role of the tumor microenvironment in regulating the scaffolding protein AKAP12 and the outputs of these downstream signaling cascades has not been fully investigated.Hypoxia, or tumor cell oxygen deficiency, is a component of the tumor microenvironment and is strongly linked to metastasis and the poor clinical outcome of patients, through the activation of specific transcriptional, translational, and signaling programs (3-8). Induction of the hypoxia-inducible transcription factor (H...